首页> 美国政府科技报告 >Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes. Executive Summary. Effective Health Care Report Number 14
【24h】

Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes. Executive Summary. Effective Health Care Report Number 14

机译:2型糖尿病患者预混配方中胰岛素类似物的比较效果,安全性和适应症。执行摘要。有效的医疗保健报告第14号

获取原文

摘要

Although oral antidiabetic agents are used as first-line agents in patients with type 2 diabetes, insulin is required in a significant number of patients at some stage during the management of diabetes to maintain optimal glycemic control. Insulin use has been suggested as a first-line therapy in patients with type 2 diabetes, either as an add-on therapy to the existing noninsulin antidiabetic medications or as a replacement for noninsulin medications. According to the National Health Interview Survey, 28 percent of patients with type 2 diabetes are using insulin either alone (16 percent) or in combination with oral antidiabetic agents (12 percent). To mimic the release of insulin from pancreatic beta-cells in response to food intake, near-physiologic insulin replacement regimens involve giving insulin at specific times in relation to meals.

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号